Inhibikase Therapeutics Inc Share Price Today: Live Updates & Key Insights
Inhibikase Therapeutics Inc share price today is $1.785, up -1.64%. The stock opened at $1.84 against the previous close of $1.83, with an intraday high of $1.87 and low of $1.775.
Inhibikase Therapeutics Inc Share Price Chart
Inhibikase Therapeutics Inc
Inhibikase Therapeutics Inc Share Price Performance
Inhibikase Therapeutics Inc Institutional Holdings
Inhibikase Therapeutics Inc Market Status
Inhibikase Therapeutics Inc Fundamentals
Market Cap 119.23 M
PB Ratio 3.0442
PE Ratio 0.0
Enterprise Value 134.29 M
Total Assets 98.60 M
Volume 8868806
Inhibikase Therapeutics Inc Company Financials
About Inhibikase Therapeutics Inc & investment objective
Company Information Inhibikase Therapeutics, Inc. operates as a clinical-stage pharmaceutical company that develops therapeutics for Parkinson's disease and related disorders. Its lead product candidate is IkT-148009, a non-receptor Abelson tyrosine kinase inhibitor, which is in Phase 2a clinical trials to the treatment of Parkinson's disease and gastrointestinal tract. The company is also developing IkT-001Pro, a prodrug of the anticancer agent imatinib mesylate to treat stable phase chronic myelogenous leukemia. Inhibikase Therapeutics, Inc. has research and development collaborations with Johns Hopkins University, Arizona State University, and Michigan State University; and a collaborative research and development agreement with Sphaera Pharma Pte. Ltd. The company was founded in 2008 and is based in Atlanta, Georgia.
Organisation Biotechnology
Employees 15
Industry Biotechnology
CEO Mr. Mark T. Iwicki
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
Inhibikase Therapeutics Inc FAQs
What is the share price of Inhibikase Therapeutics Inc today?
The current share price of Inhibikase Therapeutics Inc is $1.785.
Can I buy Inhibikase Therapeutics Inc shares in India?
Yes, Indian investors can buy Inhibikase Therapeutics Inc shares by opening an international trading and demat account with Motilal Oswal.
How to buy Inhibikase Therapeutics Inc shares in India?
You can easily invest in Inhibikase Therapeutics Inc shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy Inhibikase Therapeutics Inc shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of Inhibikase Therapeutics Inc.
Can I buy fractional shares of Inhibikase Therapeutics Inc?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of Inhibikase Therapeutics Inc?
Inhibikase Therapeutics Inc has a market cap of $119.23 M.
In which sector does Inhibikase Therapeutics Inc belong?
Inhibikase Therapeutics Inc operates in the Biotechnology sector.
What documents are required to invest in Inhibikase Therapeutics Inc stocks?
To invest, you typically need:
What is the PE and PB ratio of Inhibikase Therapeutics Inc?
The PE ratio of Inhibikase Therapeutics Inc is N/A and the PB ratio is 3.04.